We observed that AL101 had potent dose-dependent inhibitory effects on growth and NOTCH target gene expression in this model, whereas limited effects were seen in three ACC cell lines with WT NOTCH1. This suggests that the antitumor activity of AL101 may be restricted to ACC tumors with a constitutively activated NOTCH pathway. Here, NOTCH1 is linked to adrenal cortex carcinoma.